Without guidance, dosing mistakes may result in inconsistent exposure or unintended side effects, particularly when compounded medications are used
In contrast to essential amino acids that require multi-step biosynthesis, alanine can be made from pyruvate by a single transamination
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
If you experience persistent or severe fatigue while taking a GLP-1 medication, this symptom should be evaluated in the context of your overall health status and treatment goals